KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors

Cancer Research

Volumn 69, Issue 18, 2009, Pages 7175-7179

  Antonescu, Cristina R ^a   Yoshida, Akihiko ^a,c   Guo, Tianhuo ^a   Chang, Ning En ^a   Zhang, Lei ^a   Agaram, Narasimhan P ^a,b   Qin, Li Xuan ^a   Brennan, Murray F ^a   Singer, Samuel ^a   Maki, Robert G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANGIOSARCOMA; ARTICLE; AUTOPHOSPHORYLATION; CELL STRAIN COS7; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION INJURY;

ANIMALS; BREAST NEOPLASMS; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION PROFILING; HEMANGIOSARCOMA; HUMANS; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70349739292     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2068     Document Type: Article

References (20)

1. Fletcher CDM, Unni KK, Mertens F. Tumours of soft tissue and bone. Lyon (France): IARC Press; 2002.
2. Antonescu CR, Viale A, Sarran L, et al. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res 2004;10:3282-3290 (Pubitemid 38685432)
3. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264
4. Monti S, Tamayo P, Mesirov J, Golub T. Consensus clustering: a resampling based method for class discovery and visualization of gene expression microarray data. Machine Learning 2003;52:91-118.
5. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article 3.
6. Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res 1998;8:195-202. (Pubitemid 28177231)
7. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997;25:2745-2751
8. Chen K, McLellan MD, Ding L, et al. PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data. Genome Res 2007;17:659-666 (Pubitemid 46715517)
9. Major JE. Genomic mutation consequence calculator. Bioinformatics 2007;23:3091-3092
10. Segal NH, Pavlidis P, Antonescu CR, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol 2003;163:691-700. (Pubitemid 36909430)
11. Itakura E, Yamamoto H, Oda Y, Tsuneyoshi M. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol 2008;97:74-81.
12. Zietz C, Rossle M, Haas C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF upregulation in angiosarcomas. Am J Pathol 1998;153:1425-1433 (Pubitemid 28509898)
13. Casper ES, Waltzman RJ, Schwartz GK, et al. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest 1998;16:442-446 (Pubitemid 28464852)
14. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999;86:2034-2037
15. Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008;26:5269-5274
16. Schlemmer M, Reichardt P, Verweij J, et al. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTCsoft tissue and bone sarcoma group. Eur J Cancer 2008;44:2433-2436
17. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 2005;104:361-366
18. Lagrange JL, Ramaioli A, Chateau MC, et al. Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology 2000;216:197-205. (Pubitemid 30434742)
19. Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol 2001;56:22-29 (Pubitemid 32685180)
20. Chang HY, Chi JT, Dudoit S, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002;99:12877-12882